Prof. Peter Barlis

Professor Peter Barlis (MBBS, MPH, PhD, FESC, FACC, FSCAI, FRACP) is an Interventional Cardiologist and the founding editor of Heart Matters. With expertise in coronary artery disease, advanced cardiac imaging, and interventional cardiology — and fellowships of the European Society of Cardiology, the American College of Cardiology, and the Royal Australasian College of Physicians — he brings the highest level of clinical authority to everything published on this site. Heart Matters was founded on Professor Barlis's belief that patients who understand their condition are less frightened and better equipped to make decisions about their care. Every article on this site reflects that commitment.

Alcohol and the Heart: What the Evidence Actually Shows

heartmatters.com 2026 04 01T223832.942
Key Points

  • The evidence on alcohol and cardiovascular health has shifted significantly in recent years. The previously held view that moderate drinking was cardioprotective is now seriously questioned.
  • Alcohol raises blood pressure, is a significant trigger for atrial fibrillation, contributes to weight gain, and in higher quantities causes alcoholic cardiomyopathy, direct damage to the heart muscle.
  • Current evidence suggests there is no reliably “safe” level of alcohol consumption from a cardiovascular standpoint, though the absolute risk from light drinking remains low for most people.
  • The takeaway is not blanket abstinence. It is honest awareness of what alcohol does to the heart, and making informed choices about how much and how often.
  • For people with established AF, heart failure, hypertension, or cardiomyopathy, alcohol is a topic worth raising directly with their cardiologist.

Alcohol is one of the most common topics that comes up in cardiology consultations, and one where the advice has changed more than patients often realise. For years, the “J-curve” hypothesis held that moderate drinking, a glass or two of red wine a day, was actually protective for the heart. That idea shaped public perception deeply. Many patients arrive in clinic believing that their nightly glass of wine is, if anything, good for them.

The evidence base has shifted considerably. The J-curve has been substantially challenged by more rigorous epidemiological methods, and the current picture is more nuanced and more cautionary than the simple message that “moderate drinking is fine.” That does not mean the message is now blanket abstinence, but it does mean the conversation is worth more than a reassuring wave.

This article is about the honest picture: what alcohol actually does to the cardiovascular system, where the evidence is strong and where it is uncertain, and what that means practically for people who drink regularly and care about their heart health.

What Alcohol Does to the Cardiovascular System

Blood pressure

The most consistent cardiovascular effect of regular alcohol consumption is its impact on blood pressure. Even moderate regular drinking raises blood pressure, and the relationship is dose-dependent. This is not a small or theoretical effect. In someone with borderline hypertension, regular alcohol can be the difference between needing medication and not. In someone already on antihypertensive therapy, regular drinking can undermine the treatment.

Hypertension is one of the most important modifiable cardiovascular risk factors. Anything that reliably raises blood pressure is worth attention, and alcohol does this reliably.

Atrial fibrillation

The relationship between alcohol and atrial fibrillation is one of the strongest and most clinically important in cardiology. Alcohol is a direct trigger for AF episodes in susceptible individuals. The “holiday heart” phenomenon, in which AF occurs during or after heavier drinking, is well documented and reflects acute alcohol toxicity to the cardiac conduction system.

Beyond acute episodes, regular alcohol consumption is an independent risk factor for developing AF. It increases both the incidence of new AF and the recurrence rate in patients who have already been cardioverted or ablated. For patients with AF, this is not a peripheral concern. It is directly relevant to their arrhythmia burden and their stroke risk.

Weight and metabolic effects

Alcohol is energy-dense, approximately 7 calories per gram, almost as much as fat. It contributes to weight gain both directly and indirectly, by reducing dietary restraint and increasing appetite. Excess weight is itself a cardiovascular risk factor and a driver of sleep apnoea, insulin resistance, and dyslipidaemia. The contribution of alcohol to the metabolic picture is frequently underestimated by people who track their food intake but not their drinking.

Alcoholic cardiomyopathy

With sustained heavy drinking over years, direct toxic damage to the heart muscle produces alcoholic cardiomyopathy, a dilated and weakened left ventricle with reduced ejection fraction. This is reversible in its early stages with complete abstinence, but can progress to irreversible heart failure. It is one of the most important reversible causes of dilated cardiomyopathy, and is frequently under-recognised because drinking history is not always volunteered or asked about in detail.

The resveratrol myth

The specific cardioprotective reputation of red wine rested partly on resveratrol, a polyphenol in grape skins that showed promising cardiovascular effects in laboratory studies. The problem is that the concentrations needed to produce these effects in humans are orders of magnitude higher than what a glass of red wine provides. The resveratrol hypothesis has not held up in human trials. The cardiovascular benefits attributed to moderate red wine drinking are now more plausibly explained by confounding. Moderate drinkers tend to have healthier lifestyles overall, rather than the wine itself conferring any specific benefit.

The J-Curve: What It Was and Why It Has Been Challenged

The J-curve referred to the observation in older epidemiological studies that moderate drinkers had lower rates of cardiovascular events than both heavy drinkers and abstainers, suggesting a protective effect at low to moderate intake. This was the basis of the “a glass of wine is good for your heart” message.

The problem identified by more recent research using Mendelian randomisation, a method that uses genetic variants to eliminate confounding, is that the abstainer group in older studies was contaminated by “sick quitters”. These were people who had given up alcohol because of poor health, which made the abstainer group look sicker than it truly was. When this is corrected for, the J-curve largely disappears. The most rigorous current evidence suggests a linear or near-linear relationship between alcohol intake and cardiovascular risk, with no clearly protective threshold.

If you are drinking regularly and have high blood pressure or atrial fibrillation, the alcohol is not helping. In many cases it makes the underlying condition considerably harder to manage.

Professor Peter Barlis, Interventional Cardiologist

What This Means Practically

If you have… What alcohol does The conversation worth having
High blood pressure Raises BP directly, undermines medication Reducing alcohol may lower BP meaningfully without any other change
Atrial fibrillation Triggers episodes, increases recurrence after cardioversion or ablation Reducing or stopping alcohol is one of the most impactful AF management steps available
Heart failure Depresses heart muscle contractility acutely. Alcoholic cardiomyopathy if sustained Many cardiologists recommend abstinence in this setting. The specifics are worth discussing with your own doctor
No established cardiac disease Raises BP dose-dependently. Increases AF risk at higher intakes Awareness and moderation are the practical levers. Appropriate levels for your individual circumstances are a conversation with your doctor

A Note on Guidelines and Moderation

Alcohol guidelines exist across most countries but vary considerably by country, by sex, by age, and by individual health circumstances. Rather than quoting specific numbers that may not apply to your situation, the more useful message is this: moderation matters, and alcohol-free days matter.

A common practical starting point discussed in clinic is at least three alcohol-free days per week. Beyond that, the right level for any individual depends on their sex, weight, underlying health conditions, medications, and family history. This is why the more specific conversation belongs with your own doctor rather than in a general article.

If you drink regularly, an honest conversation with your healthcare professional about your drinking is one of the more useful discussions available to anyone managing a cardiovascular condition. Many people are surprised to find that reducing alcohol has a more significant impact on their blood pressure, their AF burden, or their weight than they expected, often more than other interventions they have been working hard on.

A note for people of East Asian background

An estimated 30 to 50 percent of people of East Asian heritage, including Japanese, Chinese, and Korean populations, carry a variant of the aldehyde dehydrogenase gene (ALDH2) that impairs alcohol metabolism. This produces the characteristic flushing reaction after alcohol (the “Asian flush”), and is associated with higher concentrations of the toxic intermediate acetaldehyde. Because acetaldehyde itself has direct effects on the cardiovascular system, the case for keeping intake low is particularly relevant for people who experience this flushing reaction.

Practical Steps Worth Considering

  • If you have hypertension, two to three alcohol-free weeks followed by a blood pressure check can be a useful experiment. The change is often meaningful and immediate.
  • If you have AF, keeping a diary of episodes and their relationship to drinking occasions can make the pattern clearer.
  • Building at least three alcohol-free days into each week, framed as a practical habit rather than deprivation, supports cardiovascular health.
  • Being honest about how much you are actually drinking matters. A restaurant pour of wine is typically considerably more than a standard drink measure, and the gap between perceived and actual intake is frequently significant.
  • For anyone concerned about their drinking or finding reduction difficult, a GP is a good starting point for a non-judgemental conversation.

Heart Matters Resource

When in Doubt, Get Checked Out

If you drink regularly and have high blood pressure, AF, or heart failure, a direct conversation with your cardiologist about alcohol is one of the more valuable discussions you can have. The impact on your condition may be greater than expected.

Read: When in Doubt, Get Checked Out →

Conclusion

The comfortable message that moderate drinking is heart-protective has not survived more rigorous scientific scrutiny. The current honest picture is that alcohol raises blood pressure reliably, triggers AF in susceptible individuals, and contributes to weight and metabolic risk, with no clearly protective threshold that modern evidence supports.

That does not mean the right answer for everyone is abstinence. For most people who drink lightly and have no established cardiovascular disease, the absolute risk is low and the conversation is about informed awareness rather than prohibition. For people managing hypertension, AF, or heart failure, alcohol is a modifiable factor that is frequently underestimated in its contribution to their condition.

The most useful thing this article can do is prompt that conversation. Honestly, without judgement, and with the clinical specificity it deserves.

Furosemide (Frusemide) Explained

furosemide, frusemide

Key Points

  • Furosemide is a powerful diuretic, a water or fluid tablet, used to remove excess fluid from the body in conditions such as heart failure, kidney disease and liver disease.
  • It works quickly and effectively, and is one of the most widely prescribed medications in cardiovascular medicine.
  • The most noticeable effect is a significant increase in urine output, which is the intended action of the medication.
  • Furosemide is typically taken in the morning, and sometimes again at midday if a second dose is needed. Taking it too late in the day can cause disruptive overnight urination.
  • The dose varies considerably between individuals. Some people need small doses while others require much larger amounts to achieve the same effect.
  • Regular monitoring of kidney function and electrolytes is an important part of long term furosemide use.

If you have been prescribed furosemide, you are in very good company. It is one of the most commonly used medications in cardiology and general medicine, and for good reason. It is highly effective at doing something that is genuinely important for many heart conditions: removing excess fluid from the body.

This article explains what furosemide is, why it is prescribed, what to expect when taking it, and what patients often find most surprising about this medication.

What Is Furosemide?

Furosemide is a diuretic, commonly known as a water or fluid tablet. It works by acting on the kidneys, specifically on a part of the kidney called the loop of Henle, which is why furosemide and medications like it are also called loop diuretics.

Its job is to tell the kidneys to excrete more salt and water into the urine than they otherwise would. The result is a significant increase in urine output, which reduces the total amount of fluid in the body. This is not a side effect, it is the intended action of the medication.

How furosemide works in the kidney, a three step diagram showing sodium, potassium and water being blocked from reabsorption and passing into urine
How furosemide works in the kidney tubule

Why Is It Prescribed?

Furosemide is prescribed whenever excess fluid has accumulated in the body and needs to be removed. This most commonly occurs in:

Heart failure. When the heart is not pumping as efficiently as it should, fluid can back up and accumulate in the lungs, the abdomen, and the legs. This congestion causes breathlessness, swollen ankles, and fatigue. Furosemide is a cornerstone of heart failure treatment because it directly addresses this fluid overload.

Kidney disease. Damaged kidneys do not excrete fluid as effectively, leading to fluid retention that furosemide can help manage.

Liver disease. Liver conditions such as cirrhosis can cause large amounts of fluid to accumulate in the abdomen, a condition called ascites. Furosemide is often used alongside another diuretic called spironolactone in this setting.

High blood pressure. Furosemide is occasionally used for blood pressure control, though other medications are more commonly chosen for this purpose.

Names Around the World

Furosemide is known by a number of different names depending on where you are and whether you are taking the generic or a branded version.

Generic name. Furosemide is the name used in Australia, the United Kingdom, the United States, Europe and most of the world. In some countries, and on older Australian and British prescriptions, it may be spelled frusemide. Both refer to exactly the same medication.

Common brand names include:

  • Lasix, the most widely recognised brand globally, used in Australia, the United States, the United Kingdom and many other countries
  • Frusid, used in Australia
  • Uremide, available in Australia
  • Frusehexal, available in Australia
  • Diural, used in some European countries
  • Seguril, used in Spain
  • Lasilix, used in France

Furosemide or Frusemide? They Are the Same Medication

If your doctor says frusemide, your old prescription says frusemide, or you have always known it by that name, you are not mistaken. Frusemide was the official approved name in Australia, the United Kingdom and most Commonwealth countries when the medication was first introduced in the 1960s.

In 2003 the United Kingdom and Australia officially adopted the international name furosemide, in line with the World Health Organization. Changing what an entire generation of clinicians had been saying and writing for decades takes considerably longer than a regulatory update, and you will hear both names used interchangeably in hospitals and clinics to this day.

If you travel internationally and need to continue your medication, the generic name furosemide will be understood by pharmacists in most countries, even if the brand name differs.

Available Formulations and Doses

Furosemide is available in several different forms, each suited to different clinical situations.

Tablets are the most commonly prescribed form for ongoing outpatient treatment. The standard tablet strengths available in Australia include:

  • 20mg, often used as a starting dose or for mild fluid retention
  • 40mg, the most commonly prescribed strength for heart failure and fluid management
  • 500mg, a high strength tablet sometimes known as Lasix 500. This strength is generally reserved for patients with advanced heart failure, significant diuretic resistance, or severe kidney disease, and is typically prescribed under the guidance of a cardiologist, heart failure specialist or nephrologist. It is not a first line dose and requires careful monitoring of kidney function and electrolytes.

Oral liquid preparations are available for patients who have difficulty swallowing tablets or who need a dose that falls between standard tablet strengths.

Intravenous and intramuscular injections are used in hospital settings when rapid or potent diuresis is needed. When someone is admitted with acute heart failure or severe fluid overload, furosemide given directly into a vein works within minutes and produces a much more immediate and powerful effect than the oral tablet. In hospital, furosemide can also be given as a continuous infusion through a drip when very large amounts of fluid need to be removed over a sustained period.

What to Expect When You Take It

The most immediate and noticeable effect of furosemide is a substantial increase in urination. This typically begins within 30 to 60 minutes of taking the medication and can produce a large volume of urine over several hours. For patients who are significantly fluid overloaded when they first start furosemide, the volume of urine produced can be quite striking.

This increase in urinary frequency and volume is not a problem. It is the medication working exactly as intended. The medical term for the passage of abnormally large volumes of urine is polyuria, and it is an expected feature of diuretic therapy, particularly in the early stages of treatment or after a dose increase.

As the excess fluid is removed from the body over days to weeks, the degree of diuresis typically settles to a more manageable level while the medication continues to prevent fluid from reaccumulating.

When to Take Furosemide

Timing matters with furosemide. Because the medication produces its diuretic effect within an hour of being taken, most doctors prescribe it to be taken in the morning. This way the period of increased urination occurs during waking hours rather than disrupting sleep.

When a larger total daily dose is needed, a second dose is typically prescribed at midday rather than in the afternoon or evening. Taking furosemide too late in the day means its peak diuretic effect will occur in the evening or overnight, which can significantly disrupt sleep with repeated trips to the bathroom.

If you are prescribed furosemide twice daily and find your sleep is being disrupted, it is worth discussing the timing of your second dose with your doctor. A simple adjustment in timing can make a considerable difference to quality of life without changing the total dose.

Why Doses Vary So Much Between Individuals

One of the things that surprises many patients is the wide range of doses that different people need. Furosemide doses can range from as little as 20 milligrams once daily to several hundred milligrams per day in some patients.

20mg → 500mg+
The range of daily furosemide doses used in clinical practice. The dose that is right for you depends on your kidney function, the severity of fluid overload, and how your body responds.

The reason for this variation is not simply about the severity of the underlying condition. Some people have what is called diuretic resistance, where the kidneys respond less efficiently to furosemide. This can occur in people with impaired kidney function, in those who have been on diuretics for a long time, and in some other clinical situations.

In these cases, larger doses are needed to achieve the same degree of fluid removal that a much smaller dose would produce in someone without resistance.

This is also why furosemide doses are sometimes changed over time. A dose that was very effective initially may need to be adjusted as circumstances change. Some patients find their dose increases during periods when their heart failure is less well controlled and then reduces again once things improve. This is entirely expected and is part of the way furosemide is used in clinical practice.

Monitoring While on Furosemide

Because furosemide affects the kidneys and the balance of electrolytes in the body, regular blood tests are an important part of long term treatment. The main things your doctor will monitor include:

Kidney function. Furosemide can sometimes reduce blood flow to the kidneys, particularly if the body becomes too dry from excessive diuresis. Regular checks ensure the kidneys are tolerating the medication well.

Potassium. Furosemide causes the kidneys to excrete potassium along with salt and water. Low potassium, called hypokalaemia, is one of the more common complications of long term furosemide use and can cause muscle cramps, weakness, and in more serious cases affect heart rhythm. Many patients on furosemide are also prescribed a potassium supplement or a potassium sparing diuretic such as spironolactone for this reason.

Sodium. Less commonly, furosemide can affect sodium levels, which your doctor will also keep an eye on.

What Patients Often Ask

Can I skip a dose if I am going out? This is one of the most common questions. Missing an occasional dose to manage a social commitment is understandable, but doing so regularly or skipping doses frequently can allow fluid to reaccumulate. It is worth having a conversation with your doctor about how to best manage furosemide around your lifestyle.

Will I always need it? This depends entirely on the underlying condition. Some patients take furosemide for a defined period and then stop. Others, particularly those with ongoing heart failure or chronic kidney disease, take it long term as part of their regular medication regimen.

What if I feel very thirsty or dizzy? These can be signs that the body has become too dry, sometimes called volume depletion. If you experience significant thirst, dizziness on standing, or a marked reduction in urine output, contact your doctor rather than simply drinking more fluid, as the dose may need adjustment.

The Importance of a Regular Medication Review

Furosemide does not work in isolation. Most people taking it are also prescribed several other medications for their heart, kidneys, or blood pressure, and many of these can interact with furosemide in ways that affect how the body responds.

A number of commonly prescribed medications can affect electrolyte levels, kidney function, or blood pressure when taken alongside furosemide. These include other blood pressure medications, certain pain relievers, some antibiotics, and a range of other cardiac medications. This is not a reason for concern, but it is a reason for awareness.

A regular medication review with your doctor and pharmacist is genuinely valuable for anyone taking furosemide long term. A pharmacist in particular is well placed to look across your entire medication list and identify any combinations that may warrant closer monitoring or a timing adjustment. This kind of review is not about finding problems, it is about making sure every medication you take is working as well as it possibly can.

It is also worth letting any new doctor, specialist or hospital team know that you are taking furosemide, particularly if you are prescribed a new medication, are unwell with vomiting or diarrhoea, or are preparing for a procedure. These are all situations where a temporary adjustment to your furosemide dose may be appropriate.

Heart Matters Resource

Ask About a Home Medicines Review

If you are taking furosemide alongside three or more other regular medications, you may be eligible for a Home Medicines Review with an accredited pharmacist, fully covered by Medicare. It is one of the most underused resources in Australian primary care and one of the most useful for people on long term cardiac medication.

Read: When in Doubt, Get Checked Out →

Conclusion

Furosemide is one of the most important and widely used medications in cardiovascular and kidney medicine. For many people it makes an enormous difference to daily comfort and quality of life, removing the excess fluid that makes breathing difficult and legs heavy.

If you are taking furosemide, the most important things to stay on top of are your regular blood tests, the timing of your doses, and an open conversation with your doctor or pharmacist whenever something changes. A medication review is not something to put off.

You are not alone in managing this. The team looking after you has prescribed furosemide many times and knows how to adjust it as your needs change. If something does not feel right, ask.

This article provides general information only and is not medical advice. Any decisions about your medication, dose or monitoring should be made in conversation with your cardiologist, GP or pharmacist.

More from Heart Matters

Smartwatches and Heart Health: What They Can and Cannot Detect

smartwatches smartwatch af detection

Key Points

  • Modern smartwatches can detect irregular heart rhythms, record a single-lead ECG, alert you to unusually high or low heart rates, and track heart rate variability. These are genuinely useful features, not marketing gimmicks.
  • Atrial fibrillation detection is the most clinically important capability. AF is often silent and the watch may be the first thing to flag it. This is already changing how cardiologists find and diagnose the condition.
  • A smartwatch ECG is a single-lead recording, equivalent to one view of your heart. A hospital ECG uses twelve leads. The watch cannot detect heart attacks, most structural problems, or many other arrhythmias.
  • An alert from your watch is a prompt to see your doctor, not a diagnosis. A positive AF notification needs to be confirmed with a proper clinical ECG before any treatment is considered.
  • False positives are common, particularly in younger people or those who move around during the recording. A notification does not mean you definitely have a heart problem.

Barely a week passes in a modern cardiology clinic without a patient walking in with their wrist extended, watch face up, ready to show their cardiologist something the device has picked up. Sometimes it is a graph. Sometimes it is a notification. Sometimes it is a recording that looks, unmistakably, like atrial fibrillation.

This is new. And it matters.

Consumer wearables have crossed a threshold in recent years. The technology is no longer novelty. For certain conditions, in certain patients, a smartwatch genuinely picks up things that would otherwise have gone undetected for months or years. For other conditions, it raises alarms that turn out to be nothing. Understanding the difference is what this article is about.

What Can a Smartwatch Actually Measure?

The sensors inside a modern smartwatch are more capable than most people realise. Here is what they are actually doing.

Optical Heart Rate (PPG)

Green LEDs shine into your skin and a sensor measures how light reflects off blood vessels. Changes in blood flow with each heartbeat allow the watch to calculate your heart rate and detect irregularities in the rhythm.

Single-Lead ECG

When you place your finger on the watch crown or back panel, an electrical circuit is completed through your body. The watch records the electrical activity of your heart for 30 seconds, producing a trace similar to Lead I of a standard ECG.

Heart Rate Alerts

Most watches can alert you when your resting heart rate goes above or below thresholds you set. An unexpected heart rate above 120 or below 40 at rest is worth knowing about and worth mentioning to your doctor.

Heart Rate Variability (HRV)

HRV measures the variation in time between heartbeats. It is a marker of recovery, stress, and autonomic nervous system function. Useful for general wellbeing tracking, though not a direct measure of heart disease.

The AF Detection Story

Atrial fibrillation is the most common sustained heart rhythm disorder. It affects millions of people worldwide, its prevalence rises sharply with age, and it significantly increases the risk of stroke. It is also, critically, often completely silent.

Many people live with paroxysmal AF, meaning AF that comes and goes, for months or years before it is ever detected. The Stroke Foundation estimates that AF is responsible for around one in five strokes in Australia. It is only found when a routine ECG happens to catch it, or when a stroke occurs, or when someone puts on a smartwatch.

That last possibility is what has changed the clinical landscape.

400,000+
participants enrolled in the Apple Heart Study, one of the largest cardiac screening studies ever conducted using consumer wearables to detect irregular pulse patterns suggesting atrial fibrillation
Perez MV et al. New England Journal of Medicine, 2019

The Apple Heart Study enrolled more than 400,000 participants and monitored them for irregular pulse patterns. Those who received a notification were sent a wearable ECG patch to confirm the finding. Of those who received notifications and wore the patch, 34 per cent had confirmed AF.

That sounds low. But consider the other side: these were people with no idea they might have AF, no symptoms, who would never have been referred for investigation without the watch. For those in whom AF was confirmed, the watch may genuinely have caught something that would otherwise have caused a stroke first.

The Fitbit Heart Study, published in 2021, found similar results. Using the optical sensor in Fitbit devices, the algorithm identified irregular rhythms in a large population, and those flagged were significantly more likely to have confirmed AF on subsequent testing.

I now see patients regularly who come in because their watch told them something was wrong with their heart rhythm. In several cases, it has been completely right. That is a genuinely new development in how we find atrial fibrillation.

The ECG on Your Wrist: What It Can and Cannot Do

The ECG feature on modern smartwatches is impressive technology. It is also frequently misunderstood.

A hospital 12-lead ECG records the electrical activity of your heart from twelve different angles simultaneously. It allows a cardiologist to assess rhythm, conduction, signs of previous heart attacks, and much more. A smartwatch ECG records from a single perspective for 30 seconds. Here is what that means in practice.

The smartwatch ECG CAN detect The smartwatch ECG CANNOT detect
Atrial fibrillation (irregular rhythm with absent P waves) Heart attacks, including STEMI (requires multiple leads)
Normal sinus rhythm (reassuring during symptoms) Most ischaemia or reduced blood flow to the heart
Some supraventricular arrhythmias if recorded during an episode Most structural heart abnormalities
Obvious bradycardia (very slow heart rate) Bundle branch blocks and conduction disorders reliably
Evidence prompting further investigation A normal result does not rule out heart disease

The most important line in that table is the last one. A normal ECG on your watch, recorded when you feel fine, does not mean your heart is healthy. It means your rhythm was normal at that moment, from that angle.

The Devices: What Each One Offers

Not all smartwatches are equal when it comes to cardiac monitoring. Here is where the main consumer devices currently stand.

Apple Watch

Series 4 and later

AF detection and single-lead ECG

Continuous background AF detection, on-demand 30-second ECG, and high and low heart rate alerts. Regulatory clearance in many countries including Australia. ECG results can be exported as PDF to share with your cardiologist.

Kardia by AliveCor

KardiaMobile and 6L

Dedicated ECG device

A purpose-built personal ECG device rather than a general smartwatch. Clips to a phone or watch band. The 6L version records six leads simultaneously. Worth discussing with your cardiologist if ongoing rhythm monitoring is a priority.

Samsung Galaxy

Series 4 and later

AF detection and single-lead ECG

Single-lead ECG and passive AF detection via the optical sensor. Regulatory clearance varies by country. A capable option for Android users who want cardiac rhythm monitoring in a general-purpose smartwatch.

Fitbit

Sense and Charge 6

Passive AF detection and ECG

Passive AF detection via the optical sensor and on-demand ECG recording. The Fitbit Heart Study provided good evidence for the AF detection capability. A lighter, more fitness-focused option for those who want cardiac monitoring without a full smartwatch.

When Your Watch Sends You an Alert: What to Do

This is where patients most often need guidance. An alert from your watch can feel alarming. Here is how to think about it.

You Have Received an Irregular Rhythm or AF Notification

Do not panic. A single notification, particularly in a younger person or one who was moving during the recording, has a meaningful false positive rate. It is a prompt to investigate, not a confirmed diagnosis.

Do not ignore it either. If your watch flags an irregular rhythm, particularly more than once, or if you also feel palpitations, breathlessness, or dizziness alongside it, contact your GP or cardiologist.

Save the recording. Export the ECG trace from your watch before your appointment if possible. Cardiologists can often see something useful in the raw trace even if the watch algorithm was uncertain.

A clinical ECG is needed for confirmation. No treatment for AF should begin based on a watch notification alone. A proper ECG, and in many cases a Holter monitor, is required to confirm the diagnosis and guide management.

The Limitations You Need to Understand

False positives are real. The optical sensor is susceptible to movement, a loose watch band, and poor skin contact. In younger, lower-risk populations, the majority of AF notifications may be false positives. Unnecessary anxiety and unnecessary investigations are real consequences.

False negatives also occur. Paroxysmal AF that comes and goes may simply not be happening at the moment you record. A normal reading does not mean AF is absent. Your cardiologist may still recommend a longer-duration cardiac monitor even after a normal watch ECG.

It cannot detect a heart attack. Chest pain or pressure that could represent a heart attack is a medical emergency. Call Triple Zero immediately. Do not try to record an ECG on your watch first.

It is not a substitute for clinical care. A smartwatch is a useful supplement to medical monitoring, not a replacement for it.

If You Think You Are Having a Heart Attack

Chest pain, pressure, tightness, pain spreading to the arm or jaw, sweating, or sudden severe breathlessness are potential symptoms of a heart attack. This is a medical emergency.

Call Triple Zero (000) in Australia immediately. Do not drive yourself to hospital. Do not attempt to record an ECG on your watch first. Time matters enormously and delays cost lives.

What Your Cardiologist Wants You to Know

Wear it consistently. Passive background monitoring is more valuable than on-demand recordings. Wearing it overnight, when resting heart rate is naturally lower, adds real diagnostic value.

Bring your data to appointments. Many watches allow you to export your heart rate history and ECG recordings. Having this at a consultation is genuinely useful.

Do not over-interpret every reading. A slight irregularity on one recording, a brief period of elevated heart rate during exercise, a single unusual-looking trace: these should be noted but not catastrophised. Context is provided by the clinical picture, not the watch alone.

Ask your cardiologist about dedicated ECG devices. If you have already been diagnosed with AF or another arrhythmia and your cardiologist wants you to monitor for episodes, a purpose-built ECG device may produce better-quality recordings. Your cardiologist can advise which approach suits your situation.

Conclusion

Can smartwatches detect heart problems? Yes, some of them, in some circumstances, with meaningful accuracy. The AF detection story in particular is genuinely compelling, and cardiologists are seeing its real-world impact every week.

But a smartwatch is not a cardiologist on your wrist. It is a screening tool with real limitations, a false positive rate that deserves respect, and a fundamental inability to diagnose the most time-critical cardiac emergencies.

Used well, with realistic expectations and a good relationship with a doctor who can contextualise what it finds, a modern smartwatch is a valuable addition to your heart health toolkit.

Related Articles

Does a Coffee a Day Keep AF at Bay?

coffee AF
Key Points

  • A new clinical trial published in JAMA found that patients with atrial fibrillation who continued drinking around one cup of coffee a day were 39% less likely to have a recurrence of AF compared to those who stopped completely.
  • This is the first randomised clinical trial to directly test whether coffee triggers AF episodes, overturning decades of routine clinical advice to avoid caffeine.
  • The finding does not mean patients should increase their coffee intake, and it does not apply to everyone. The trial involved patients who were already moderate coffee drinkers.
  • As with all research, there are limitations, and guidelines have not yet changed. Talk to your cardiologist before changing anything about your daily habits.

If you have been told you have atrial fibrillation, there is a good chance someone, whether a doctor, a nurse, or a well-meaning friend, has suggested you cut back on coffee. For years, caffeine has been viewed with suspicion in the context of heart rhythm disorders, and many patients with AF have quietly given up their morning cup out of caution. If you experience palpitations or an irregular heartbeat and are not sure whether it is related to AF, our dedicated article on palpitations explains what different sensations mean and when to seek help.

A major new clinical trial, published in JAMA in 2026 and conducted across five hospitals in Australia, the United States, and Canada, has now challenged that longstanding advice in a way that will be meaningful for many people living with AF.

The short version: in patients who already drank moderate amounts of coffee, continuing to drink around one cup a day after cardioversion was not harmful, and may actually have been protective against the return of irregular heart rhythm.

What is the DECAF trial?

DECAF stands for Does Eliminating Coffee Avoid Fibrillation, which neatly captures the question the researchers set out to answer. It is the first randomised clinical trial ever conducted on this specific question, which makes it a landmark study even by the standards of cardiology research.

The trial enrolled 200 adults with persistent AF who were all scheduled for cardioversion, the procedure that uses a controlled electrical impulse to reset the heart back into a normal rhythm. The average age of participants was 69 years and 71% were male. All were moderate coffee drinkers, consuming around seven cups per week, which is roughly one cup a day, at some point in the previous five years.

After successful cardioversion, patients were randomly assigned to one of two groups. One group was asked to continue drinking at least one cup of caffeinated coffee each day. The other group was asked to avoid all coffee and caffeine entirely, including decaffeinated coffee. Most participants were already being treated for AF with anticoagulation and some with antiarrhythmic or rate control medications, and these were continued throughout the trial. Both groups were then followed for six months to see whose heart rhythm stayed normal and whose returned to AF. The coffee group maintained their habit of around seven cups per week throughout the trial, while the abstinence group reduced to essentially none.

☕ Coffee group
47% of patients who continued drinking coffee had a recurrence of AF or atrial flutter within six months.

🚫 No coffee group
64% of patients who avoided all caffeine had a recurrence of AF or atrial flutter within six months.

📉 The difference
Patients who continued drinking coffee were 39% less likely to have a recurrence of AF compared to those who abstained entirely.

✅ Safety
Emergency visits and hospitalisations were similar between both groups. No deaths occurred in either group during the trial.

☕ What does this mean in practice?
For every 6 people with AF who continued drinking their daily coffee after cardioversion, approximately 1 avoided a recurrence that they would otherwise have had. That is a meaningful real-world benefit, and a number worth discussing with your cardiologist.

The result was statistically significant, meaning it is unlikely to be explained by chance alone. The lead investigator, Professor Christopher Wong of the University of Adelaide, described the results as astounding, noting that the trial suggests coffee is not only safe but potentially protective for patients with AF. Importantly, the DECAF trial was funded by the National Institutes of Health, with no pharmaceutical or industry sponsorship involved, which strengthens confidence in the independence of the findings.

Why might coffee help rather than hurt?

For decades, the assumption was that caffeine, as a stimulant, would make the heart more prone to irregular rhythms. The DECAF trial suggests the reality is more nuanced. The researchers and commentators offered several possible explanations for why moderate coffee consumption might actually be associated with fewer AF episodes.

Adenosine blockade
Caffeine blocks adenosine receptors in the heart. Adenosine can promote the conditions that allow AF to develop and persist, so blocking it may have a protective effect.

Anti-inflammatory effects
Coffee contains compounds beyond caffeine that have anti-inflammatory properties. Inflammation plays a role in the development of AF, so reducing it may help maintain normal rhythm.

Physical activity
Coffee is associated with increased physical activity, and exercise is known to reduce AF burden. Patients in the coffee group may have been more active as a result.

Caffeine withdrawal
Abruptly stopping caffeine causes physiological changes that may themselves be disruptive to heart rhythm. Regular moderate consumption avoids this stress on the body.

What are the limitations of this trial?

No single clinical trial, however well-designed, changes medical practice on its own, and the DECAF researchers themselves were careful to highlight several important limitations that patients should understand.

The trial enrolled 200 patients, which is a relatively modest number in the world of clinical cardiology. While the result was statistically significant, a larger study could either strengthen or modify these findings. The open-label design, meaning that both patients and researchers knew which group each person was in, could also influence how symptoms were reported or how often patients sought medical attention. There were also some differences in baseline characteristics between the two groups: the abstinence group was on average two years older and included more women, which may have influenced the results despite statistical adjustments.

The researchers also noted that AF episodes were detected through routine clinical care rather than a standardised monitoring schedule, which means some episodes in either group may not have been captured.

For years I have had the conversation in clinic about coffee and AF. Most patients ask about it, and until now the honest answer was that we did not have good randomised evidence either way. The DECAF trial changes that. For patients who are already moderate coffee drinkers, this is genuinely reassuring. But it is not a signal to start drinking more, and it is not a study of patients who never drank coffee. Context matters, and the conversation with your cardiologist still matters.

What does this mean for you?

If you have AF and you have been worried about your morning coffee, this trial offers genuine reassurance. For patients who are already moderate coffee drinkers, the best available evidence now suggests that continuing to drink around one cup a day is not harmful and may, if anything, be beneficial for heart rhythm stability after cardioversion.

However, it is important to understand what this trial does not tell us. It was not conducted in people who do not drink coffee at all, so it does not suggest that non-coffee-drinkers should start. It does not apply to large amounts of caffeine. It does not mean that every patient with AF should drink more coffee. And it does not override the advice of your own cardiologist, who knows your specific heart anatomy, medications, and circumstances.

Clinical guidelines have not yet been updated to reflect this trial, and further research will follow. In the meantime, the most sensible message is that you no longer need to feel guilty about your morning cup, but as always, any significant changes to your lifestyle or habits are worth discussing with your clinical team first.

Read More, Heart Matters

Our dedicated articles on atrial fibrillation cover what AF is, how it affects stroke risk, and the full range of treatment options available, explained in plain language.

Understanding AF and Stroke Risk →
AF Treatment Options →

A note before you refill the kettle
This trial is interesting and genuinely reassuring for moderate coffee drinkers with AF. But it is not a prescription to drink more coffee, and it is not a reason to change anything without speaking to your cardiologist first. Every patient is different, every heart is different, and the right conversation is the one you have with the clinician who knows your case. Bring this up at your next appointment and ask what it means for you specifically.

Conclusion

The DECAF trial is a genuinely important piece of research that challenges a longstanding assumption in cardiology. For decades, patients with AF have been advised, often without strong evidence, to avoid caffeine. The first properly conducted randomised trial on this question tells a different story: for moderate coffee drinkers, continuing to enjoy one cup a day after cardioversion appears to be safe and may reduce the likelihood of AF returning.

It is a finding worth knowing about. It is also a reminder that in medicine, advice that has been repeated for many years is not always grounded in the evidence we now have the tools to generate. This trial gave us that evidence, and it is genuinely good news for the many patients with AF who have been quietly missing their coffee.

More from Heart Matters

References

  • Wong CX, Cheung CC, Montenegro G, et al. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial. JAMA. 2026;335(4):317-325. doi:10.1001/jama.2025.21056
  • First presented by Christopher X. Wong, MBBS, MPH, PhD, at the American Heart Association Scientific Sessions 2025, New Orleans, LA, November 9, 2025. Published in print JAMA January 27, 2026
  • Funding: The DECAF trial was supported by the National Institutes of Health (NIH), National Heart, Lung and Blood Institute. No commercial or industry funding was involved in this research.

Nitrates for Angina: GTN Spray, Patches, and Long-Acting Tablets Explained

Nitrates

Key points

  • Nitrates are one of the oldest and most effective treatments for angina, the chest pain or tightness caused by reduced blood flow to the heart
  • They come in several forms: a spray or tablet under the tongue for fast relief, skin patches for all-day protection, and long-acting tablets taken once or twice daily
  • The most important side effect is a sudden drop in blood pressure causing headache, flushing, or dizziness, these are common and manageable, not dangerous
  • Nitrates must never be taken with erectile dysfunction medicines such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra), the combination can cause a dangerous and potentially life-threatening drop in blood pressure
  • Tolerance can develop with long-acting nitrates, your doctor will advise a nitrate-free period each day to keep the medication working effectively

If you have been prescribed a small spray or tablet to carry with you for chest pain, you are holding one of the most effective medicines in cardiovascular care, and one with a history stretching back more than 150 years.

Nitrates have been used to treat angina since the 1870s. They remain a cornerstone of treatment today not because medicine hasn’t moved on, but because they work, quickly, reliably, and in a way that no other class of medication quite replicates. Understanding what they do, how to use them correctly, and what to watch for will help you feel confident with a medicine that may become an important part of your daily life.

What nitrates do

Angina occurs when the heart muscle is not receiving enough blood, usually because the coronary arteries that supply it have become narrowed by coronary artery disease. The heart muscle is working hard but not getting enough oxygen to meet the demand. The result is chest pain, pressure, tightness, or heaviness, often brought on by exertion and relieved by rest.

Nitrates work by relaxing the walls of blood vessels. They cause the veins throughout the body to widen, a process called vasodilation which reduces the amount of blood returning to the heart with each beat. This reduces the workload the heart muscle has to perform, lowering its oxygen demand and relieving the mismatch between supply and demand that causes angina.

Nitrates also cause the coronary arteries themselves to relax and widen, improving blood flow to the heart muscle directly. This dual effect, reducing demand and improving supply simultaneously, is what makes them so effective.

Nitrates do not treat the underlying coronary artery disease. They manage symptoms by making the heart’s workload more manageable. This is an important distinction, and one worth discussing with your cardiologist if you are relying on them frequently.

The different types of nitrates

Nitrates come in several forms, each suited to a different purpose. Some are designed to act within minutes for immediate relief. Others release slowly throughout the day to provide ongoing protection against angina episodes.

Sublingual glyceryl trinitrate, the spray or tablet under the tongue

Glyceryl trinitrate GTN, is the fast-acting form most people associate with angina. It comes as a small spray applied under the tongue, or as a small tablet placed under the tongue to dissolve. Both forms work within one to three minutes and last for approximately 20 to 30 minutes.

GTN is used in two ways. First, as an immediate treatment when an angina episode occurs, used at the onset of symptoms for rapid relief. Second, as a preventive measure before activities you know are likely to trigger angina, climbing stairs, walking uphill, or any exertion that has provoked symptoms before. Used this way, GTN can allow you to undertake activities that would otherwise cause discomfort.

Your cardiologist or pharmacist will give you specific instructions on how and when to use your GTN, including how many doses are appropriate and at what point you should call an ambulance rather than continuing to wait. It is important to have that conversation before you need it, so you feel confident and prepared if an episode occurs.

If GTN is not working, when to call an ambulance

Your doctor or pharmacist will advise you on how many doses of GTN to use and when to stop and call an ambulance. Make sure you know this before you need it.

As a general principle, chest pain that is not relieved by GTN, is more severe than your usual angina, or is accompanied by breathlessness, sweating, or pain spreading to your arm or jaw should be treated as a potential heart attack. Call an ambulance immediately, do not drive yourself to hospital.

Australia: 000 · UK: 999 · USA/Canada: 911 · Europe: 112

Transdermal nitrate patches

Glyceryl trinitrate patches are adhesive patches applied to the skin, typically the chest, upper arm, or back, that release a steady, controlled amount of GTN through the skin over the course of the day. They are changed once daily and provide sustained protection against angina episodes throughout the wearing period.

Patches are useful for patients with frequent angina who need consistent background coverage rather than relying solely on on-demand treatment. They are applied in the morning and removed after a set number of hours, usually 12 to 14 hours, to allow a nitrate-free period overnight. This nitrate-free period is important to prevent tolerance developing.

Whether you wear your patch during the day or overnight depends on the pattern of your symptoms, your doctor is best placed to advise which timing works for you.

The site of application should be rotated daily to reduce the chance of skin irritation. Common sites include the chest wall, upper arm, shoulder, or back. Avoid areas of broken or irritated skin.

Long-acting oral nitrates

Isosorbide mononitrate and isosorbide dinitrate are oral tablets taken once or twice daily to provide longer-lasting angina protection. They are available in standard and modified-release formulations.

Isosorbide mononitrate, the more commonly prescribed of the two, is typically taken as a once-daily modified-release tablet in the morning. The modified-release formulation delivers the medication gradually throughout the day while allowing drug levels to fall overnight, preserving the nitrate-free period that prevents tolerance.

These oral nitrates are used for patients with more frequent or predictable angina where regular prevention is preferable to on-demand treatment alone. They are often prescribed alongside other angina medicines such as beta-blockers or calcium channel blockers.

Type Form Onset Duration Used for
GTN spray / tablet Under the tongue 1–3 minutes 20–30 minutes Immediate relief or pre-activity prevention
GTN patch Skin patch 30–60 minutes 12–14 hours All-day background protection
Isosorbide mononitrate Oral tablet 30–60 minutes Up to 24 hours (MR) Regular daily prevention
Isosorbide dinitrate Oral tablet 20–45 minutes 4–6 hours Regular prevention, often twice daily

Side effects, what to expect

The most common side effects of nitrates are a direct consequence of how they work, by dilating blood vessels and lowering blood pressure. They are very common, particularly when you first start taking nitrates, and they usually ease as your body adjusts.

Headache is the most frequently reported side effect, particularly with the first few doses. The same vasodilation that relieves angina also widens the blood vessels in the scalp, causing a throbbing headache. For most patients this improves significantly within a few days as the body adapts. Paracetamol can be taken to manage the headache in the meantime. If headaches are severe or persistent, speak to your doctor, adjusting the dose or switching formulation often helps.

Flushing and warmth a feeling of heat or redness in the face, is also common and has the same vascular mechanism as the headache. It is temporary and harmless.

Dizziness and light-headedness occur because nitrates lower blood pressure. Sitting or lying down when using GTN spray significantly reduces this risk. Standing up quickly after taking a nitrate, particularly after exercise or in warm weather, can cause a more pronounced drop in blood pressure.

Tolerance the gradual reduction in effectiveness with regular use, is specific to long-acting nitrates and patches. It does not occur with occasional use of GTN spray. To prevent tolerance, long-acting nitrates are prescribed with a structured nitrate-free period each day, usually overnight, during which the body resets its sensitivity to the medication. Your doctor will advise on the specific timing for your prescription.

Headache with the first dose of GTN is very common, for most patients it improves significantly within days as the body adjusts
British Heart Foundation, Nitrate medicines guidance

The critical interaction with erectile dysfunction medicines

This is the most important safety message associated with nitrate medicines, and one that every patient taking nitrates needs to know clearly.

Nitrates must never be taken within 24 to 48 hours of erectile dysfunction medicines including sildenafil (Viagra, Revatio), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Spedra). These medicines belong to a class called PDE5 inhibitors and they work by a related mechanism to nitrates. When taken together, the two drugs cause an additive and potentially catastrophic drop in blood pressure, severe hypotension that can cause fainting, heart attack, stroke, or death.

This interaction applies regardless of the dose of either medication and regardless of the time gap, the window of risk with tadalafil (Cialis) extends to 48 hours due to its longer duration of action.

This is not a reason to avoid discussing sexual health with your cardiologist. Erectile dysfunction is common in men with cardiovascular disease and is itself an important cardiovascular risk marker. There are approaches to managing both conditions safely, but the conversation needs to happen with your doctor, not by managing it yourself. If you are taking nitrates and have questions about sexual activity or erectile dysfunction, please raise it at your next appointment.

Other important cautions

Low blood pressure. Nitrates should be used with caution if your blood pressure is already low. If you feel very dizzy or faint after taking GTN, sit or lie down immediately and inform your doctor.

Aortic stenosis. Patients with significant narrowing of the aortic valve, aortic stenosis, may not tolerate nitrates well, as their heart depends on maintaining adequate filling pressure. Your cardiologist will advise you specifically if this applies to your situation.

Hypertrophic cardiomyopathy. Similarly, nitrates may worsen symptoms in some patients with hypertrophic cardiomyopathy, a condition where the heart muscle is thickened. Always confirm with your specialist whether nitrates are appropriate for you.

Alcohol. Alcohol enhances the blood pressure-lowering effect of nitrates and increases the risk of dizziness and faintness. Take care with alcohol consumption while on nitrate medicines.

Other blood pressure medicines. Nitrates add to the blood pressure-lowering effects of other antihypertensives, including ACE inhibitors, ARBs, beta-blockers, and calcium channel blockers. This combination is often intentional and beneficial, but worth being aware of in terms of dizziness risk, particularly on standing.

Practical tips for taking nitrates

Keep your GTN spray with you at all times. It is of no use at home if you need it while out. Many patients keep one spray in their pocket or bag and a second at home.

Check the expiry date. GTN spray and tablets have a limited shelf life and lose potency over time. Check the expiry date regularly and replace as needed.

Store correctly. GTN is sensitive to light and heat. Keep it in its original container, away from direct sunlight and warm environments. Do not store in a car glovebox in warm climates.

Know when to use it preventively. If you know that a particular activity tends to trigger your angina, climbing stairs, walking to the car in cold weather, using a dose of GTN two to three minutes before that activity can prevent the episode rather than treat it.

Tell all your doctors and pharmacists. Always inform any healthcare professional prescribing a new medicine that you are taking nitrates, so that interactions, particularly with blood pressure medicines, can be checked.

Heart Matters Resource

If your GTN is not working

If your chest pain is not relieved by GTN, is more severe than usual, or is accompanied by breathlessness or pain spreading to your arm or jaw, call an ambulance immediately. Do not drive yourself to hospital.

Read: Chest Pain, Causes and When to Seek Help →

Conclusion

Nitrates are a remarkably effective class of medicine, fast-acting, well-understood, and with a track record measured in decades. Knowing how to use your GTN spray correctly, understanding the difference between on-demand and preventive use, and being aware of the critical interaction with erectile dysfunction medicines will allow you to use these medicines safely and confidently.

If your angina symptoms are changing, becoming more frequent, occurring at rest, or requiring more GTN than usual, that is a signal to speak with your cardiologist rather than simply increasing your nitrate use. Changing symptom patterns deserve reassessment, not just more medication.

Used well, nitrates give you genuine control over a condition that can otherwise feel unpredictable. That is worth understanding clearly.

More from Heart Matters

Statins: What Patients Ask Me Most

statins
Key Points

  • Statins are among the most prescribed medications in the world, and among the most stopped without anyone being told.
  • Most of what circulates online about statins is negative. The clinical evidence tells a more balanced story.
  • Statins do more than lower cholesterol, in people at genuine cardiac risk, research shows they stabilise vulnerable plaques and reduce the inflammatory process that triggers heart attacks.
  • Side effects are real and should never be dismissed. Muscle aches, fatigue, and memory concerns deserve a proper conversation with your doctor, and there are options.
  • Not everyone needs a statin. For those prescribed one after a cardiac event or because of genuinely high risk, the evidence for staying on it is strong.

I hear some version of this almost every week in clinic. A patient sits down, and somewhere in the conversation they mention, sometimes apologetically, that they have stopped their statin. Or they are thinking about stopping it. Or they started it and felt different, and nobody ever explained why they were on it in the first place.

I understand this completely. The conversation around statins in the lay media and on social media is overwhelmingly negative. Muscle pain, memory loss, fatigue, “I haven’t felt like myself since I started.” These are real experiences, and they deserve to be taken seriously, not brushed aside with a blanket reassurance that statins are safe.

What I want to do here is share the conversation I try to have in clinic: honest, balanced, and grounded in what the evidence actually shows.

What a Statin Actually Does

Most patients are told their statin lowers cholesterol. That is true, but it is a bit like saying a seatbelt stops you moving forward. Technically accurate, but it misses what matters.

The more important action of a statin, particularly for someone who has already had a heart attack or has significant coronary artery disease, is what it does to the plaques inside the artery wall.

Let me explain what I mean by that.

The Plaque Story: What Is Actually Happening Inside

Cross-section illustration of a coronary artery showing a lipid-rich plaque with inflammatory cells, alongside an actual OCT image from Prof. Peter Barlis's PhD thesis showing the view from inside a coronary artery
Left: an illustration of a coronary artery cross-section showing a lipid-rich plaque with inflammatory cells at the fibrous cap. Right: an actual OCT image from my PhD thesis, the view from inside a coronary artery, with the dark region indicating a lipid pool beneath the vessel wall.

I often show patients this image in clinic. On the left is an illustration of what a vulnerable plaque looks like in cross-section, the open vessel with blood flowing through it, and beneath the surface, a pool of soft, lipid-rich material. You can see the grey star-shaped cells sitting right at the boundary between the plaque and the vessel lining. Those are macrophages, inflammatory cells that have migrated into the plaque and are, in a sense, destabilising it from within.

On the right is a real image, from my own PhD research using a technology called optical coherence tomography, or OCT, which involves threading a tiny light-based probe inside a living coronary artery. The bright golden ring is the artery wall. The dark shadow at the bottom is exactly what it looks like on the illustration: a lipid pool sitting just beneath the surface, visible in extraordinary detail from inside the vessel itself.

The thin layer of tissue covering that lipid pool is called the fibrous cap. In a vulnerable plaque, this cap is thin and fragile, and those inflammatory cells are actively weakening it further. When the cap ruptures, the lipid-rich contents spill into the bloodstream. A clot forms almost instantly. Depending on how large that clot is, and which artery is involved, the result is either a smaller heart attack, what we call an NSTEMI, or a complete blockage and a larger event, an STEMI.

This is what most heart attacks actually are. Not a gradual narrowing that finally closes off. A rupture. A sudden event triggered by a plaque that may not have been causing any symptoms at all.

Where Statins Come In

Here is what changes the conversation for me, and what I explain to every patient who asks why they need to stay on their statin.

Statins stabilise vulnerable plaques. They reduce the inflammatory cells infiltrating the cap, those macrophages that are weakening it from within. Over time, research shows they can thicken the fibrous cap itself, making it more resistant to rupture. They change the biology of the plaque, not just the number on a blood test.

This is why, in patients who have already had a heart attack or who have established coronary disease, the evidence for statins is so compelling. It is not primarily about the LDL number. It is about reducing the likelihood that a vulnerable plaque will rupture and cause another event. This is also the reason the relationship between statins and your calcium score is more nuanced than it first appears.

~25%
Reduction in major cardiovascular events with high-intensity statin therapy in high-risk patients, regardless of starting cholesterol level
Cholesterol Treatment Trialists’ (CTT) Collaboration meta-analyses

Who Actually Needs a Statin?

This is where I want to be direct: not everyone does.

There is a legitimate conversation to be had about patients who have been started on a statin primarily because a cholesterol number crossed a threshold, without a proper discussion of their individual cardiovascular risk, their age, their other risk factors, and what the medication is actually expected to achieve for them personally.

If you were prescribed a statin and never had a proper conversation about why, that is worth revisiting with your GP or cardiologist. Cardiovascular risk calculators, used by doctors worldwide, look at the full picture: age, blood pressure, smoking status, family history, and cholesterol together. The number on its own tells only part of the story. Emerging tools like the hs-CRP test and imaging such as the coronary calcium score can add further context in the right patient.

Where the evidence is clearest and most compelling is in people who have already had a cardiac event, those with established coronary artery disease, and those at genuinely high cardiovascular risk. For these patients, the benefit of staying on a statin is well established and significant.

Questions Patients Ask Me Most

These are the questions I hear most often in clinic, answered as honestly as I can. As always, these are for general information, and any decision about your own medication should be made in conversation with your doctor.

Will statins damage my muscles?

Mostly reassuring

Muscle discomfort affects around 5–10% of people on statins. Serious muscle damage is genuinely rare. Significant pain, weakness, or dark urine should prompt a call to your doctor, but general aching is often manageable with a dose change or switch to a different statin, which your doctor can discuss with you.

Can statins affect my memory?

Mostly reassuring

The overall evidence does not support a link between statins and dementia or significant cognitive decline. Some people notice a change in mental clarity, an experience that deserves investigation, not dismissal. This is worth raising with your doctor rather than simply stopping the medication.

Do I really need one if I feel fine?

Worth discussing

Not everyone does. If a statin was started purely because a number crossed a threshold, with no discussion of individual risk, that conversation is worth revisiting with your GP. For people who have had a cardiac event or have established coronary disease, the evidence is strong regardless of how they feel.

Can I take a break from my statin?

Please discuss first

This is a conversation to have with your doctor before making any change. Many people quietly stop and never mention it, but in those with coronary artery disease or a prior heart attack, statins are doing something important beyond lowering a number. There are almost always options if the current medication is not suiting you.

Are there alternatives if I can’t tolerate statins?

Yes, options exist

Every-other-day dosing works well for many people who experience daily side effects. Switching to a different statin often resolves muscle symptoms. Ezetimibe is a well-tolerated tablet that lowers cholesterol through a different mechanism and is often used alongside or instead of a statin. For high-risk patients who cannot tolerate statins at all, PCSK9 inhibitors are a highly effective option. All of these alternatives are best discussed with your doctor before making any changes.

Does it matter which statin I’m on?

Yes, they differ

Statins vary in potency and side effect profile. Rosuvastatin (Crestor) and atorvastatin (Lipitor) are the most potent. Some people tolerate one significantly better than another. If side effects are an issue, the answer is often a switch or dose adjustment, a discussion worth having with your doctor before considering stopping altogether.

Should I take my statin in the morning or at night?

It depends on the statin

There are some differences between statins, and timing can play a small role, but the most important factor is consistency. Taking it at the same time each day matters more than which hour is chosen. For a fuller explanation of the pharmacology behind this, see our article on the timing of cholesterol-lowering medications. Your doctor is best placed to advise on what suits your particular medication and routine.

Can I lower my cholesterol naturally?

Worth discussing

Many products claim to lower cholesterol naturally, most have not been tested in proper clinical trials, and caution is warranted. Two approaches with reasonable evidence behind them are plant sterols and a generous fibre intake. A Mediterranean-style diet remains the most well-studied dietary pattern for cardiovascular risk. None of these replace a statin when one is clinically indicated, but they can be meaningful complements. Any supplement addition is worth discussing with your doctor first.

The Side Effects, Taking Them Seriously

Muscle aches and pains are the most commonly reported side effect, and they are real. Roughly 5–10% of people on statins experience some degree of muscle discomfort, though true muscle damage (myopathy) is considerably rarer.

What is also real is the nocebo effect, the phenomenon where knowing a medication might cause symptoms makes those symptoms more likely to be noticed and attributed to it. Large blinded trials have shown that many people who report muscle symptoms on statins experience the same symptoms on placebo. That does not mean the symptoms are not real, it means the relationship between statins and those symptoms is more complex than it first appears.

Memory and cognitive concerns are raised frequently, and understandably, given how much has been written about them. The overall evidence does not support a causal link between statins and dementia or significant cognitive decline. Some people do notice a change in mental clarity when starting a statin, and this deserves investigation rather than dismissal.

My strong view is this: side effects should never simply be accepted. There are several different statins, they vary in their potency and their side effect profiles, and some people tolerate one far better than another. Dose adjustments matter. Every-other-day dosing works well for some patients. And if a statin genuinely cannot be tolerated, there are alternative lipid-lowering options, including ezetimibe and PCSK9 inhibitors, that achieve excellent results. All of this is a conversation to have with your doctor.

If you are experiencing side effects on your statin, the conversation with your doctor is always worth having before stopping. There is almost always something that can be tried.

What I Tell My Patients

When a patient comes to me having stopped their statin because of something they read online, I don’t argue with them. I show them the image above, the plaque, the cap, the inflammatory cells, and I explain what the evidence shows about what these medications actually do inside the artery wall. Most of the time, that conversation changes things.

Conclusion

Statins are not perfect medications, and the decision to take one, or stay on one, deserves a proper, individual conversation. Not every person with a mildly elevated cholesterol needs a statin, and side effects should never be dismissed or simply tolerated.

But for those with established heart disease or genuinely high risk, the evidence is clear: statins do something that no other medication currently does as well. They get inside the artery wall and stabilise the plaques that cause heart attacks. That is worth understanding, and worth a conversation before making a decision either way.

If you have questions about your statin, or you have stopped taking it and haven’t told your doctor, please bring it up at your next appointment. There are options, and the conversation is always worth having.

Related Reading

Stay Informed

The latest heart health news, research and resources — delivered to your inbox.